Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2018-08-20 10:26:37
Reporting Period:
Accepted Time:
2018-08-20 10:26:37
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
811641 Immucell Corp ICCC In Vitro & In Vivo Diagnostic Substances (2835) 010382980
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1384044 Scott David Tomsche C/o Immucell Corporation
56 Evergreen Drive
Portland ME 04103
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.10 Per Share Acquisiton 2018-08-16 3,000 $6.67 75,789 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
  1. (1) This figure includes 2,322 shares of common stock held by immediate family members of Dr. Tomsche.